Stratos Wealth Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,502
Closed -$246K 1738
2026
Q1
$246K Sell
1,502
-135
-8% -$20.8K ﹤0.01% 1434
2025
Q4
$285K Sell
1,637
-1,266
-44% -$231K ﹤0.01% 1319
2025
Q3
$418K Buy
2,903
+688
+31% +$84.3K ﹤0.01% 1093
2025
Q2
$223K Buy
+2,215
New +$169K ﹤0.01% 1281

Other funds holding INSM

Stratos Wealth Partners's INSM Position: Q2 2026 in Review

Stratos Wealth Partners sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,502 shares — an estimated $246K sold.

Stratos Wealth Partners first reported a position in INSM in Q2 2025 and held it in 4 quarters. The position peaked at $418K in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Stratos Wealth Partners reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Stratos Wealth Partners sold 1,502 Insmed shares in Q2 2026, an estimated $246K.
  • Stratos Wealth Partners first reported a position in Insmed in Q2 2025 and held it in 4 quarters.
  • Stratos Wealth Partners's Insmed position peaked at $418K in Q3 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.